HK1179616A1 - 碳青霉烯類衍生物或其水合物的晶型及其製備方法與用途 - Google Patents

碳青霉烯類衍生物或其水合物的晶型及其製備方法與用途

Info

Publication number
HK1179616A1
HK1179616A1 HK13106724.5A HK13106724A HK1179616A1 HK 1179616 A1 HK1179616 A1 HK 1179616A1 HK 13106724 A HK13106724 A HK 13106724A HK 1179616 A1 HK1179616 A1 HK 1179616A1
Authority
HK
Hong Kong
Prior art keywords
hydrates
crystalline form
preparation methods
carbapenem derivative
carbapenem
Prior art date
Application number
HK13106724.5A
Other languages
English (en)
Inventor
黃振華
董岩岩
Original Assignee
山東軒竹醫藥科技有限公司 號
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN 201010190636 external-priority patent/CN102267996A/zh
Application filed by 山東軒竹醫藥科技有限公司 號 filed Critical 山東軒竹醫藥科技有限公司 號
Publication of HK1179616A1 publication Critical patent/HK1179616A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK13106724.5A 2010-06-03 2013-06-06 碳青霉烯類衍生物或其水合物的晶型及其製備方法與用途 HK1179616A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN 201010190636 CN102267996A (zh) 2010-06-03 2010-06-03 碳青霉烯类衍生物或其水合物的晶型及其制备方法
CN201110104082 2011-04-25
PCT/CN2011/000925 WO2011150679A1 (zh) 2010-06-03 2011-06-01 碳青霉烯类衍生物或其水合物的晶型及其制备方法与用途

Publications (1)

Publication Number Publication Date
HK1179616A1 true HK1179616A1 (zh) 2013-10-04

Family

ID=45066149

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13106724.5A HK1179616A1 (zh) 2010-06-03 2013-06-06 碳青霉烯類衍生物或其水合物的晶型及其製備方法與用途

Country Status (4)

Country Link
US (1) US8822445B2 (zh)
CN (1) CN103025733B (zh)
HK (1) HK1179616A1 (zh)
WO (1) WO2011150679A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8318716B2 (en) * 2009-12-31 2012-11-27 Kbp Biosciences Co., Ltd. Carbapenem derivatives
US20130079322A1 (en) * 2010-05-21 2013-03-28 Xuanzhu Pharama Co., Ltd. Crystalline of carbapenem derivative or its hydrate, preparation methods and uses thereof
US9840506B2 (en) 2014-04-28 2017-12-12 Jw Pharmaceutical Corporation Crystal of doripenem, and preparation method therefor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI250160B (en) * 1999-07-06 2006-03-01 Sankyo Co Crystalline 1-methylcarbapenem compound
CA2404703C (en) * 2000-03-31 2007-06-05 Shionogi & Co., Ltd. Novel crystal form of pyrrolidylthiocarbapenem derivative
AR035728A1 (es) 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
EP1852436A4 (en) * 2005-02-15 2010-02-24 Shionogi & Co PROCESS FOR PRODUCING CARBAPENEME DERIVATIVE AND CRYSTALLINE INTERMEDIATE THEREOF
WO2006101062A1 (ja) * 2005-03-22 2006-09-28 Daiichi Sankyo Company, Limited １－アルキルピロリジン構造を有するカルバペネム誘導体の製造方法
US8293895B2 (en) 2007-06-28 2012-10-23 Kbp Biosciences Co., Ltd. Carbapenem derivatives
US8318716B2 (en) * 2009-12-31 2012-11-27 Kbp Biosciences Co., Ltd. Carbapenem derivatives
CN102250095A (zh) * 2010-05-21 2011-11-23 山东轩竹医药科技有限公司 碳青霉烯衍生物或其水合物的晶型及其制备方法
US20130079322A1 (en) * 2010-05-21 2013-03-28 Xuanzhu Pharama Co., Ltd. Crystalline of carbapenem derivative or its hydrate, preparation methods and uses thereof

Also Published As

Publication number Publication date
CN103025733B (zh) 2015-11-25
CN103025733A (zh) 2013-04-03
WO2011150679A1 (zh) 2011-12-08
US20130090325A1 (en) 2013-04-11
US8822445B2 (en) 2014-09-02

Similar Documents

Publication Publication Date Title
IL266168A (en) Heteroaryl compounds and methods of their use
HK1259135A1 (zh) Vmat2的苯並喹啉酮抑制劑
HK1243417A1 (zh) 吡啶酮和氮雜吡啶酮化合物及使用方法
HRP20180829T1 (hr) Spojevi tioacetata, pripravci i postupci za uporabu
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
HK1178149A1 (zh) 吡唑- -基-雜環基-甲酰胺化合物及其使用方法
EP2536283B8 (en) Phenyl-heteroaryl derivatives and methods of use thereof
EP2569425A4 (en) ENDORIBONUCLEASE COMPOSITIONS AND METHOD FOR THEIR USE
EP2536756A4 (en) HSA-RELATED COMPOSITIONS AND USE PROCESSES
ZA201303793B (en) Substituted quinoline compounds and methods of use
EP2584897A4 (en) COMPOSITIONS CONTAINING RESVERATROL AND METHODS OF USE
HK1222128A1 (zh) 用於製備氣霧劑的方法和組合物
EP2539348A4 (en) CEPHALOSPORIN DERIVATIVES AS BETA LACTAMASE HEMMER AND COMPOSITIONS THEREFOR AND METHOD FOR THEIR USE
EP2663565A4 (en) HEZEROARYL COMPOUNDS AND METHOD FOR USE THEREOF
EP2596112A4 (en) ACETYCYSTEIN COMPOSITIONS AND USE METHOD THEREFOR
EP2548859A4 (en) PREPARATION OF METHYL-D3-AMINE AND SALTS THEREOF
EP2539444A4 (en) COMPOSITIONS AND METHODS FOR THE PRODUCTION OF L-HOMOALANINE
IL229968A0 (en) Tetrazolyloxy derivatives and methods for their production
HK1179616A1 (zh) 碳青霉烯類衍生物或其水合物的晶型及其製備方法與用途
EP2616463A4 (en) PREPARATION OF CRYSTALLINE BAZEDOXIFES AND THEIR SALTS
GB201301307D0 (en) Crystalline form of prulifloxacin and processes for its preparation
GB201002278D0 (en) composition and method of preparation
AU2011903137A0 (en) Compounds and methods of their use - IV
AU2011905060A0 (en) Methods and Preparation and Uses of Xanthorrhoeaceae Compositions
PL391303A1 (pl) Nowa pochodna pirymidopirymidyny i sposób wytwarzania nowej pochodnej pirymidopirymidyny